Global Asset Purchase Partnering Terms and Agreements in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
24
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

Dublin, May 22, 2018 (GLOBE NEWSWIRE) -- The "Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018" report has been added to ResearchAndMarkets.com's offering. The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2012-2018 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The focus of the report is on partnerships for business, product, technology and royalty assets where partners have entered an agreement to dispose of or acquire said assets. Companies may seek to dispose of an asset simply because it is surplus to requirements. Or it may seek to dispose of assets in order to raise funds to invest in others parts of its business. Or it may be due to a regulatory requirement to dispose of certain business or product assets as a result of a pending business merger in order to meet competition regulations. The report provides access to asset purchase deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. The report focuses on four primary types of asset available for purchase:

  • Business assets - the most common asset exchanging hands. Business assets are in the form of a business unit or subsidiary of a parent company. Common assets include territorial businesses or non-core businesses such as an OTC or diagnostics business, separate from the core business operations
  • Product assets - in the form of marketed product, clinical phase development compound, or drug delivery-compound combination. These assets are commonly available as a result of a merger or change in direction of the selling company. The buyer acquires the asset for global or territorial exploitation. It is often the case that the acquiring company is normally a competitor to the seller, but in this situation the trade is of mutual benefit
  • Royalty assets - where a specialist investment company acquires the rights to future royalty payments in return for payment of a lump sum payment to the licensor for the product
  • Technology asset - where a buyer is acquiring a technology platform, research program, patent portfolio or other intellectual property asset. The acquisition is often due to the technology being surplus to a sellers interests, but may also be as a consequence of a sale of assets in advance of the seller entering liquidation

This report contains a comprehensive listing of over 1,000 asset purchase deals announced since 2012 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual asset purchase contract documents as submitted to the Securities Exchange Commission by companies and their partners. Key benefits

  • In-depth understanding of asset purchase deal trends since 2012
  • Analysis of the structure of asset purchase agreements with numerous real life case studies
  • Comprehensive access to over 1,000 actual asset purchase deals entered into by the world's biopharma companies
  • Detailed access to actual asset purchase deals entered into by leading biopharma companies
  • Insight into the terms included in a asset purchase agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

  • Trends in asset purchase dealmaking in the biopharma industry since 2012
  • Analysis of asset purchase deal structure
  • Case studies of real-life asset purchase deals
  • Access to over 1,000 asset purchase deal records
  • The leading asset purchase deals by value since 2012
  • Most active asset purchase dealmakers since 2012
  • The leading asset purchase partnering resources

Available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Therapeutic area
  • Technology type

Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in Asset Purchase dealmaking 2.1. Introduction 2.2. Types of assets purchased 2.3. Trends in Asset Purchase deals since 2012 2.3.1. Asset Purchase dealmaking by year since 2012 2.3.2. Asset Purchase dealmaking by phase of development since 2012 2.3.3. Asset Purchase dealmaking by industry sector since 2012 2.3.4. Asset Purchase dealmaking by therapy area since 2012 2.3.5. Asset Purchase dealmaking by technology type since 2012 2.3.6. Asset Purchase dealmaking by most active company since 2012 2.4. Reasons for entering into asset purchase partnering deals 2.4.1. Business assets 2.4.2. Product assets 2.4.3. Royalty assets 2.4.4. Technology assets 2.5 The emergence of royalty asset purchase deals 2.5.1. Primary players in royalty asset purchase deals 2.5.3. The future of royalty asset purchase deals 2.6. The role of IP auction houses in asset purchase deals 2.6.1. Leading IP auction companies 2.7. The future of asset purchase agreements Chapter 3 - Overview of Asset Purchase deal structure 3.1. Introduction 3.2. Asset purchase agreement structure 3.3. Example asset purchase agreements 3.3.1. Case study 1: Product asset: QLT - Valeant Pharmaceuticals 3.3.2. Case study 2: Business asset: Merck and Co - Bayer 3.4. Anatomy of a royalty asset purchase agreement 3.5. Example royalty asset purchase agreements 3.5.1. Case study 3: Royalty asset: BioTime Acquisition Corporation- Geron Corporation Chapter 4 - Leading Asset Purchase deals 4.1. Introduction 4.2. Top Asset Purchase deals by value Chapter 5 - Top 50 most active Asset Purchase dealmakers 5.1. Introduction 5.2. Top 50 most active Asset Purchase dealmakers Chapter 6 - Asset Purchase deals including contracts directory 6.1. Introduction 6.2. Asset Purchase deals with contracts since 2012 Appendices Appendix 1 - Asset Purchase dealmaking by companies A-Z Appendix 2 - Asset Purchase dealmaking by industry sector Appendix 3 - Asset Purchase dealmaking by stage of development Appendix 4 - Asset Purchase dealmaking by therapy area Appendix 5 - Asset Purchase dealmaking by technology type For more information about this report visit https://www.researchandmarkets.com/research/p...asset?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biotechnology, Pharmaceuticals, Diagnostics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 177

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Radiotherapy Suit Challenges New EviCore Guidelines

Updated Category News Views 94

Turning Up the Heat on EviCore Winter Park, Florida—home of sunshine, oranges, and now a heated legal standoff. On November 16, 2026, the Radiotherapy Access Alliance dropped a bombshell lawsuit against EviCore over its recent guideline flip-flop. EviCore reversed its stance on low-dose radiation therapy (LDRT) for arthritis and other pesky pain, leaving patients—and...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 98

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 185

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 188

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Main Capital Partners Backs TaskRay: Salesforce Expansion

Updated Category News Views 64

Investing in Transformation Main Capital Partners has thrown in with TaskRay, joining hands with Cloud Coach and JustOn to shake up customer delivery on Salesforce. These three are cooking up an ambitious AI-driven platform that's gunning to streamline from project management to financial operations. Main's stepping into this mix with a mindset that aligns with over 800...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 152

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 17

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Ozelle Unveils AI-Powered Hematology Tool at MEDICA 2026

Updated Category News Views 116

Pioneering a New Era in Hematology In the fast-paced world of blood analysis, standing still means being left in the dust. Ozelle, with its AI-powered innovative tool, is making waves at MEDICA 2026 in Düsseldorf. Meet O-Cyte 1, an automated hematology analyzer that's merging high-resolution cell imaging with routine CBC (Complete Blood Count) testing. Sounds like...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 35

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating the Rising Tide of AI-Driven Cyber Threats

Updated Category News Views 118

The Evolving Landscape of Cyber Threats In today's world, artificial intelligence is rapidly changing the nature of cyber threats. Recent studies reveal that a significant number of companies have encountered AI-driven cyberattacks, highlighting a critical gap in their defense strategies. Despite this alarming trend, many organizations are yet to fully embrace AI in their...

Continue Reading
Insight into the Bullish Movements Surrounding DPZ Stock

Updated Category News Views 58

Understanding the Options Dynamics for Domino's Pizza Investors are expressing a clear bullish sentiment towards Domino's Pizza as evident from the recent options market activities. Analyzing the options history for Domino's Pizza (DPZ), we found a total of 10 significant trades. These trades reveal that approximately 50% of traders leaned towards bullish strategies while...

Continue Reading
PDD Holdings Faces Legal Challenges Over Securities Violations

Updated Category News Views 230

PDD Holdings Faces Legal Challenges Over Securities Violations PDD Holdings, Inc. is currently facing a major class action lawsuit. This legal action stems from accusations that the company misled investors about potential compromises to its applications, raising serious concerns about user privacy, particularly regarding unauthorized access to private messages. Details...

Continue Reading
Significant Shareholder Announcement for Kenmare Resources

Updated Category News Views 98

Major Holdings Notification for Kenmare Resources Plc Understanding the dynamics of major shareholdings is essential for investors and stakeholders alike. Kenmare Resources Plc has recently updated the market regarding key holdings that affect its share structure. The notification process is transparent, with clear communication ensuring that all relevant details are...

Continue Reading
Exploring High-Yield Dividend Stocks for Income Investors

Updated Category News Views 65

Dive into Dividend Investing Dividend investing is often overlooked, especially in an era dominated by the latest advancements in technology and artificial intelligence. While the allure of tech growth may be tempting, savvy investors understand the enduring value of reliable income-generating stocks. The world of dividend stocks is vast, and their potential for...

Continue Reading